Merck

Merck Beats Estimates on Stronger Sales of Diabetes Products
Bloomberg
Tue, 10/27/15 - 09:25 am
Merck
earnings
What to Expect From Merck Earnings
Yahoo/24-7 Wall St
Mon, 10/26/15 - 04:33 pm
Merck
earnings
Merck's Keytruda extends survival in lung cancer study
Yahoo/Reuters
Mon, 10/26/15 - 04:32 pm
Merck
Keytruda
lung cancer
anti-PD-1 immunotherapy
Battle Royale: Merck & Co. vs. Pfizer
Motley Fool
Sun, 10/25/15 - 06:29 pm
Merck
Pfizer
Merck Discounts Remicade by 25% in U.K. to Fend Off Rivals
Bloomberg
Fri, 10/23/15 - 09:20 am
Merck
Remicade
UK
drug discounts
rheumatoid arthritis
Merck HCV Treatment: The Next Big Breakthrough?
Bidness, ETC
Wed, 10/21/15 - 10:31 am
Merck
hepatitis C
elbasvir/grazoprevir
MK-36822
MK-84083
Opdivo expansion may displace Keytruda
Medical Marketing and Media
Sat, 10/17/15 - 03:15 pm
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
New Merck Study Shows Combos Will Drive Celgene Growth: RBC
Barron's
Fri, 10/16/15 - 07:44 pm
Merck
Celgene
Pomalyst
Merck’s CETP inhibitor seems to have very low chances of success after Eli Lilly’s similar drug failed in its late stages
Bidness, ETC
Thu, 10/15/15 - 09:41 am
Merck
Eli Lilly
CETP inhibitors
Anacetrapib
evacetrapib
Ex-Merck employees gets 3 years in prison for insider trading
Yahoo/Reuters
Tue, 10/13/15 - 10:17 pm
Merck
insider trading
Merck, Incyte eye a winning cancer combo with widened collaboration
Fierce Biotech
Tue, 10/13/15 - 09:57 am
Merck
Incyte
cancer
Keytruda
epacadostat
Merck cholesterol drug's odds dim after Lilly failure
Yahoo/Reuters
Tue, 10/13/15 - 09:48 am
Merck
Eli Lilly
Anacetrapib
evacetrapib
This Double-Whammy Sent Merck Shares Notably Lower in September
Motley Fool
Fri, 10/9/15 - 11:19 am
Merck
Jardiance
Januvia
Keytruda
Merck notches another win in India patent battle over diabetes bestsellers
Fierce Pharma
Wed, 10/7/15 - 09:53 pm
Merck
India
patents
diabetes
Glenmark
Januvia
Janumet
U.K. cost gatekeeper says 'OK' to Merck's Keytruda for advanced skin cancer
Fierce Pharma
Wed, 10/7/15 - 03:15 pm
UK
Merck
Keytruda
skin cancer
NICE
UBS analysts weigh in on FDA’s expanded approval of Merck’s Keytruda for the treatment of lung cancer
Bidness, ETC
Wed, 10/7/15 - 10:05 am
Merck
non-small cell lung cancer
FDA
Keytruda
Keytruda's label confers edge for Opdivo
Medical Marketing and Media
Mon, 10/5/15 - 06:02 pm
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
PDL-1 inhibitors
Merck's Keytruda snags FDA approval for NSCLC, but label is narrow
Fierce Pharma
Fri, 10/2/15 - 04:57 pm
Merck
Keytruda
FDA
non-small cell lung cancer
Merck adds oncolytics combo study to its huge Keytruda effort
Fierce Biotech
Thu, 10/1/15 - 02:17 pm
Merck
DNX-2401
Keytruda
3 Big Drugs Likely To Hit The Market Soon
Investors.com
Wed, 09/30/15 - 04:56 pm
Merck
Keytruda
Shire
Lifitegrast
Gilead Sciences
Genvoya

Pages